Work

Hydroxyrubicin, a deaminated derivative of doxorubicin, inhibits mammalian DNA topoisomerase II and partially circumvents multidrug resistance

Year: 1994

Type: article

Source: International Journal of Cancer

DOI: 10.1002/ijc.2910580115

Authors: Eric Solary, Vi‐He Ling, Roman Perez‐Soler, Waldemar Priebe, Yves Pommier

Institutions: National Institutes of Health, National Cancer Institute, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Ligue Contre le Cancer, National Institutes of Health, National Cancer Institute

Awards: G331047307, TARGET SPECIFICITIES OF DEAMINATED ANTHRACYCLINES

OpenAlex ID: W2007663268

FWCI: 0.858

Cites: 24

Cited by: 17

Related to: 10